Immunocore Holdings (IMCR) Change in Accured Expenses (2023 - 2026)
Immunocore Holdings (IMCR) reported Change in Accured Expenses of $27 million for Q2 2026, down 19.9% from $33.73 million a year earlier.
Powered by 
Analysis
Immunocore Holdings (IMCR) Change in Accured Expenses (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Immunocore Holdings' Change in Accured Expenses came in at $11.8 million, down 75.5% year-over-year; for FY2025, it was $15.89 million, down 77.8% from FY2024.
- Change in Accured Expenses has a four-year compound annual growth rate of 10.4% (FY2021 to FY2025).
- By year, Change in Accured Expenses came in at $71.5 million in FY2024 (+82.9%), $39.09 million in FY2023 (-6.4%), $41.76 million in FY2022 (+290.9%) and $10.68 million in FY2021.
- Five-year quarterly Change in Accured Expenses spans a low of -$22.03 million in Q4 2025 and a high of $33.73 million in Q2 2025.
- Year over year, Change in Accured Expenses gained in two of the last four quarters, with growth averaging 25.0%.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$8.3 million (Q1 2026), -$22.03 million (Q4 2025) and $15.13 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Immunocore Holdings | 1.53 Bn | -1.95 Bn | 114.84 Mn | 27.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.00 Mn |
| Mar 31, 2026 | -8.30 Mn |
| Dec 31, 2025 | -22.03 Mn |
| Sep 30, 2025 | 15.13 Mn |
| Jun 30, 2025 | 33.73 Mn |
| Mar 31, 2025 | -10.94 Mn |
| Dec 31, 2024 | -1.23 Mn |
| Sep 30, 2024 | 26.70 Mn |
| Jun 30, 2024 | 26.86 Mn |
| Mar 31, 2024 | 19.17 Mn |
| Dec 31, 2023 | 15.98 Mn |
| Sep 30, 2023 | 11.23 Mn |
| Jun 30, 2023 | 7.30 Mn |
| Mar 31, 2023 | 4.58 Mn |
API Access
Immunocore Holdings Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=IMCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "IMCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=IMCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();